# Uruguay Chemicals Export Opportunities (HS 28-38) ![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp) > Yugalinks sector export playbook Explore Uruguay HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities. ## Overview - Exporter: Uruguay (URY) - Sector: Chemicals - HS chapters: HS 28-38 - Latest trade year: 2024 - Sector exports: $49.0M - Products: 28 - Buyer markets: 25 - Average CAGR: +5.3% - Global sector size: $542.2B ## Product portfolio | Product | Global size | Your exports | Opportunity | CAGR | Markets | Share | | --- | ---: | ---: | ---: | ---: | ---: | ---: | | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $274.2B | $13.2M | $98.0B | -8.9% | 19 | +0.0% | | HS 293719 - Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $18.7B | $1.8M | $32.5B | +69.3% | 2 | +0.1% | | HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $66.4B | $3.9M | $24.6B | +14.3% | 9 | +0.0% | | HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $31.2B | $20.9K | $21.4B | -11.5% | 13 | +0.0% | | HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $30.4B | $11.4M | $16.7B | +13.8% | 7 | +0.1% | | HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $11.8B | $98.8K | $11.7B | +3.0% | 2 | +0.0% | | HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.5B | $9.4M | $10.3B | +36.2% | 3 | +0.1% | | HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $14.4B | $1.5M | $8.6B | -7.6% | 4 | +0.0% | | HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $8.1B | $637.7 | $6.7B | -13.3% | 3 | +0.0% | | HS 330300 - Perfumes and toilet waters | $11.1B | $163.9K | $6.4B | -12.5% | 5 | +0.0% | | HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $15.0B | $58.9K | $6.2B | +8.8% | 5 | +0.0% | | HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $7.6B | $298.0K | $5.8B | +33.8% | 2 | +0.0% | | HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $4.4B | $67.8 | $4.9B | -35.8% | 1 | +0.0% | | HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $10.7B | $1.6M | $4.7B | -0.0% | 4 | +0.0% | | HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $4.5B | $20.4K | $3.8B | +154.5% | 2 | +0.0% | | HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $4.8B | $521.4K | $2.8B | +154.6% | 1 | +0.0% | | HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $4.4B | $1.2M | $2.5B | -1.3% | 3 | +0.0% | | HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $2.3B | $83.9 | $2.1B | -4.3% | 2 | +0.0% | | HS 380893 - Herbicides, anti-sprouting products and plant-growth regulators: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $2.0B | $61.1K | $1.7B | -2.1% | 1 | +0.0% | | HS 293590 - Sulphonamides: n.e.c. in heading no. 2935 | $1.1B | $56.1K | $1.4B | +36.0% | 1 | +0.1% | | HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $14.3K | $990.0M | +1.7% | 1 | +0.0% | | HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.0B | $22.9 | $981.1M | -17.7% | 1 | +0.0% | | HS 310559 - Fertilizers, mineral or chemical: containing the two fertilizing elements nitrogen and phosphorus, other than nitrates and phosphates | $1.2B | $200.5K | $962.9M | -0.8% | 1 | +0.0% | | HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $1.6B | $75.4K | $871.1M | +3.0% | 1 | +0.0% | | HS 300449 - Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $1.5B | $1.4K | $841.5M | -58.5% | 1 | +0.0% | | HS 281512 - Sodium hydroxide (caustic soda): in aqueous solution (soda lye or liquid soda) | $557.0M | $4.7K | $764.8M | -10.8% | 1 | +0.0% | | HS 310210 - Fertilizers, mineral or chemical: nitrogenous, urea, whether or not in aqueous solution | $2.3B | $66.8K | $746.8M | +6.6% | 1 | +0.0% | | HS 380891 - Insecticides: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $1.6B | $3.3M | $708.3M | +3.3% | 1 | +0.2% | ## Best markets - USA, Puerto Rico and US Virgin Islands (USA): $84.3B calculated opportunity across 13 products. - Switzerland, Liechtenstein (CHE): $36.6B calculated opportunity across 4 products. - Germany (DEU): $31.9B calculated opportunity across 12 products. - Netherlands (NLD): $18.2B calculated opportunity across 4 products. - Spain (ESP): $12.5B calculated opportunity across 7 products. - Italy (ITA): $10.6B calculated opportunity across 3 products. - Canada (CAN): $10.5B calculated opportunity across 7 products. - China (CHN): $9.3B calculated opportunity across 4 products. - Brazil (BRA): $8.6B calculated opportunity across 8 products. - Mexico (MEX): $8.6B calculated opportunity across 4 products. - United Kingdom (GBR): $8.4B calculated opportunity across 5 products. - France (FRA): $7.4B calculated opportunity across 4 products. ## Growth stars - HS 382600: +154.6% average CAGR, $2.8B calculated opportunity. - HS 381512: +154.5% average CAGR, $3.8B calculated opportunity. - HS 293719: +69.3% average CAGR, $32.5B calculated opportunity. - HS 330210: +36.2% average CAGR, $10.3B calculated opportunity. - HS 293590: +36.0% average CAGR, $1.4B calculated opportunity. - HS 293399: +33.8% average CAGR, $5.8B calculated opportunity. - HS 300215: +14.3% average CAGR, $24.6B calculated opportunity. - HS 300212: +13.8% average CAGR, $16.7B calculated opportunity. - HS 382200: +8.8% average CAGR, $6.2B calculated opportunity. - HS 310210: +6.6% average CAGR, $746.8M calculated opportunity. ## Diversification opportunities - HS 300490: 19 buyer markets, $98.0B calculated opportunity. - HS 382499: 13 buyer markets, $21.4B calculated opportunity. - HS 300215: 9 buyer markets, $24.6B calculated opportunity. - HS 300212: 7 buyer markets, $16.7B calculated opportunity. - HS 330300: 5 buyer markets, $6.4B calculated opportunity. - HS 382200: 5 buyer markets, $6.2B calculated opportunity. - HS 300439: 4 buyer markets, $8.6B calculated opportunity. - HS 330499: 4 buyer markets, $4.7B calculated opportunity. - HS 330210: 3 buyer markets, $10.3B calculated opportunity. - HS 293499: 3 buyer markets, $6.7B calculated opportunity. ## Method Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology). ## Data sources - Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/) - CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf) This page presents derived Yugalinks views of reported observations and calculated indicators.